Europäische Förderprogramme zu Medizin

Transcription

Europäische Förderprogramme zu
Medizin- und Gesundheitsthemen
für Forscher, Unternehmer und
öffentliche Träger
23.Februar 2011
Kooperationskatalog
Europäische Förderprogramme zu Medizin- und Gesundheitsthemen für Forscher, Unternehmen und
öffentliche Träger .................................................................................................................................... III
Das Enterprise Europe Network ............................................................................................................. IV
European Technology Profiles / Europäische Technologieprofile........................................................... V
EU Proposals/ EU Projektvorschläge ..................................................................................................... VI
Enterprise Europe Network Sachsen-Anhalt
[Partner]
tti Magdeburg GmbH
Bruno-Wille- Straße 9
D-39108 Magdeburg
Helga Ilchmann
Tel.: +49 (0)391 7 44 35 42
Fax: +49 (0)391 7 44 35 44
e-mail: [email protected]
http://www.tti-magdeburg.de
- II -
Europäische Förderprogramme zu Medizin- und
Gesundheitsthemen
für Forscher, Unternehmen und öffentliche Träger
Die Europäische Union steht vor bedeutenden Herausforderungen, sowohl die
Gesundheit und die medizinische Versorgung ihrer Bürger betreffend als auch im
Hinblick auf globale Gesundheitsfragen und langfristige Perspektiven. Der
demographische Wandel verändert nicht nur die Erkrankungsmuster sondern auch die
Anforderungen an Prävention und Therapieformen sowie das Gesundheitssystem. Die
Entwicklung und Validierung neuer Therapien für häufige und schwere Erkrankungen ist
hierbei von wachsender Bedeutung. Um diese Prozesse zu unterstützen ist es wichtig,
dass die Übertragung von Grundlagenforschungsergebnissen in die Anwendung
beschleunigt und gestärkt wird.
Der
vorliegende
Kooperationskatalog
enthält
eine
Auswahl
europäischer
Kooperationsangebote und EU Projektvorschläge zum Thema Medizin und Gesundheit.
Bei Interesse vermittelt das Enterprise Europe Network (EEN) gerne den Kontakt.
- III -
Das Enterprise Europe Network
Das Enterprise Europe Network ist das größte Netzwerk von Kontaktpunkten, die
europäischen Unternehmen, vor allem kleinen und mittleren Unternehmen (KMU),
Informationen und Beratung im Zusammenhang mit der Europäischen Union anbieten.
Das Enterprise Europe Network wurde im Jahr 2008 durch die Europäische Kommission
auf Grundlage der früheren Netzwerke der Euro Info Centres bzw. Innovation Relay
Centres gegründet.
Das EEN hat es sich zur Aufgabe gemacht, KMU bei der Internationalisierung ihrer
Geschäftstätigkeit
wie
auch
dem
Aufbau
von
grenzüberschreitenden
Geschäftspartnerschaften zu unterstützen. Zu den Kernaktivitäten des Netzwerks gehört
außerdem die Sammlung und Weiterleitung von Reaktionen der Unternehmen auf die
KMU-Politik der Europäischen Kommission sowie die Organisation des transnationalen
Technologietransfers und die Beratung von KMU bezüglich der Teilnahme an den
Forschungsrahmenprogrammen der EU.
Das Netzwerk bietet Unternehmen und Unternehmern in mehr als 40 Ländern, darunter
den 27 EU-Mitgliedsstaaten, den Beitrittskandidaten, den Mitgliedern der Europäischen
Wirtschaftszone und anderen Drittländern, konkrete und effektive Lösungen aus einer
Hand an. In Sachsen-Anhalt wird das EEN durch zwei Organisationen vertreten, die
Industrie und Handelskammer Magdeburg (IHK) (Koordinator) und die tti Magdeburg
GmbH (Partner).
Das Enterprise Europe Network ist sowohl in Bezug auf seine geographische Reichweite
als auch auf den breiten Umfang der den KMU und anderen Wirtschaftsakteuren
angebotenen integrierten Dienstleistungen einzigartig. Das wird durch das koordinierte
Handeln von nahezu 600 Partnerorganisationen, die annähernd 4.000 erfahrene
Mitarbeiter für die Stärkung der Wettbewerbsfähigkeit der europäischen Unternehmen
bereitstellen, ermöglicht.
Weitere Informationen:
www.enterprise-europe-network.ec.europa.eu
www.een-sachsen-anhalt.de
- IV -
European Technology Profiles / Europäische
Technologieprofile
Reference No.
PROFILE TITLE
PROFILTITEL (Deutsch)
Seite
08 ES 28F8 2RXX
eHealth care system that
autonomously detects elder
people when they fall at
home
eHealth care System, welches
selbstständig erkennt, wenn
ältere Menschen zu Hause
fallen
1
08 IT 53V2 0IW3
Microfluidics system for
increasing biocompatibility
structures
Mikrofluidsystem zur Erhöhung
der Biokompaitbilitätsstrukturen
2
09 IT 55X5 3DPP
Medical devices and systems
for diagnostics of respiratory
diseases, home monitoring
and telemedicine applications
Medizinische Geräte und
Systeme zur Diagnose von
Atemwegserkrankungen, zur
hausgebundenen
Überwachung und für
Telemedizin Anwendungen
3
09 TR 98OF 3FHH
Healthcare Information
Systems Platform
Plattform zur Informationen
über Systeme fürs
Gesundheitswesen
5
10 BG 0538 3K61
New technology for
development of optoelectronic and laser medical
equipement
Neue Technologie für die
Entwicklung von Laser- und
optoelektronischer
medizinischer Ausrüstung
7
10 DE 0855 3JK2
Expertise in innovative drug
delivery forms for children
and the elderly as well as for
orphan diseases treatment
and individualised medicine
Expertise in einer innovativen
Form der Arzneimittelvergabe
an Kinder und ältere Personen
sowie für individualisierte
Medizin
8
10 ES 24E1 3IPO
An Ambient Intelligence
Based Multi-Agent System for
Alzheimer Health Care
Ein “Ambient Intelligence
Based Multi-Agent System” für
die Pflege von an Alzheimer
erkrankten Menschen
9
10 ES 27F3 3GL9
Design technique of
microsurgery for the
implantation of tissue or the
release of biological
substances in the brain tissue
Designtechnik für die
Implantation von Gewebe oder
Freilegung von biologischen
Substanzen im Gehirngewebe
11
10 ES 28F9 3H4Q
Simulator technology for
clinical medical cases
Simulationstechnologie für
klinische medizinische Fälle
12
10 GB 41n8 3ILK
Bioanalysis expertise in
human health research
studies and drug
development
Bioanalytische Expertise in der
Erforschung menschlicher
Gesundheit und
Medikamentenentwicklung
14
10 GB 46P4 3IHL
Real time patient flow and
bed management system
used in hospital environments
Managementsystem für die
Echtzeit Planung
Patientenfluss und
Bettenbelegung in
Krankenhäusern
16
10 GB 46P4 3IZG
A novel solution for surface
cleaning products (such as
wipes and sprays) in
Neuartige Lösung für
Oberflächenreinigungsprodukte
im Gesundheitswesen
18
-V-
Reference No.
PROFILE TITLE
PROFILTITEL (Deutsch)
Seite
healthcare environments
10 NL 60AH 3JZE
The development and
production of medical and
healthcare instruments based
on the processing of
physiological signals
Entwicklung und Produktion
von medizinischen
Instrumenten, basierend auf
der Signalverarbeitung
physiologischer Signale
19
11 BE 0213 3KAQ
Organs isolated perfusion
technology
Technologie zur Durchblutung
isolierter Organe
21
11 DE 1375 3K6G
General diagnostic device to
control organs and therapies
Diagnoseapparat zur Kontrolle
von Organen und Therapien
23
10 IL 80EP 3HV3
PHR (Personal Health
Records) software
applications that can be
integrated with a USB Flash
memory drive
PHR Software, die in einen
USB Stick integriert werden
kann
24
10 IL 80EP 3JIY
Technologies, applications
and capabilities for
telemedicine, telehealth and
telecare
Technologien, Applikationen
und Möglichkeiten für
Telemedizin, Telegesundheit
und Telepflege
25
10 ES 25E2 3J2K
Seeking new technologies to
foster Health Services
Gesuch nach einer neuen
Technologie um den
Gesundheitsservice zu fördern
26
EU Proposals/ EU Projektvorschläge
TITLE
TITEL(deutsch)
Seite
PS: FP7-KBBE-2011-5-SME : SME sought
for project under topic Processed foods
with lower salt, fat and sugar content
(Ref: 10 FR 38m5 3IW2)
PS: FP7-KBBE-2011-5-SME: für ein
Projekt, welches nach einer Möglichkeit
sucht, Lebensmittel mit vermindertem Salz,
Fett und Zucker Gehalt herzustellen, wird
ein KMU gesucht
(Ref: 10 FR 38m5 3IW2)
27
Improvement and Development of new
multicentre clinical trials to detect and
reduce diabetes complications
Verbesserung und Entwicklung einer
neuen multizentrischen klinischen Studie
zur Aufklärung und Verminderung von
Komplikationen bei Diabeteserkrankungen
28
Network preventative and therapeutic
health
Netzwerk für präventive und therapeutische
Gesundheit
29
Health care for women affected by violence
in Austria
Gesundheitsversorgung für Frauen, die
Opfer von Gewalt geworden sind (in
Österreich)
30
- VI -
EU Förderprogramme zu Medizin und Gesundheit
Cooperation Catalogue
23.02.11
Halle
Reference: BBS
08 ES 28F8 2RXX
Country: Spain
eHealth care system that autonomously detects elder people when they fall at home
Abstract:
A Spanish university developed a system that autonomously detects when a person fall using several
off-the-shelf cameras.It is focused to reduce the time of arrival of emergency services, triggering an
alarm (image or SMS). The system provides this service even when the people are unconscious and it
is built using cheap parts. The research group seeks partners in eHealth industry to implement this
technology through commercial agreements with technical assistance.
Description:
The system works with regular (and cheap) cameras, and it is based on advanced computer vision
techniques to continuously estimate the 3D position of the tracked person. It has three building blocks:
(1) image analysis, for people color learning and motion detectors;
(2) 3D estimation,
(3) Alarm configuration.
Innovative Aspects:
There are similar products for tele-assistance, which are based on necklaces with an emergency
button, that person is required to press in case of emergency. Such systems do not work properly
when the patient loses consciousness due to a faint.
The developed technology has been especially designed for such faint situations, as it is based on
image analysis and is completely autonomous. No action at all is required from the patient. In addition
it is non intrusive, as the person does not need to wear any gadget.
The system uses cameras, which are passive sensors, it does not require any actuation from the
patient. It is completely autonomous and non intrusive. In addition it is not an expensive system, which
benefits its marketing and sale. Regular and off the self cameras are enough for the proper operation
of the system.
The technology is able to recognise "danger zones" in the ambient of elder people, such as balconies
or electric plugs.
Development Stage:
Available for demonstration
Collaboration Details:
License Agreement;Adaptation to specific needs;
-1-
23.02.11
Halle
Reference: BBS
08 IT 53V2 0IW3
Country: Italy
Microfluidics system for increasing biocompatibility structures
Abstract:
An Italian Research Centre has developed a novel Microfluidics system concerns handling and
manipulation of minute amounts of fluids; volumes thousands of times smaller than a common droplet
without any. This microfluidics devices are indifferently fabricated in Silicon, in polymeric materials,
Dry Film in SU8, and in Glass. We are able to use a PolySiC layer as a covering layer to increase the
structures biocompatibility.
Description:
The researchers have developed novel strategies to fabricate easily micro fluidic structures for several
application. In particular they are developing a integrated PCR in a microfluidic structures and
different system for biological material separation and system for the fabrication of polymeric fuel cell.
All this activities are developed using different approaches but the reduction in size is one of the most
important aspect. The fabrication of miniaturised version of conventional laboratory equipment such as
pumps, heaters, electrophoresis columns and valves is the basic approach to create a Laboratories
on-a-chip. In laboratory are present all the equipment for the fabrication of innovative system including
the deposition of SiC materials as a high resistant material to harsh environment and high
biocompatibility.
Innovative Aspects:
The innovation is based on fabbrication of microfluidics system using non conventional approach and
non conventional materials like as Silicon carbide and poly SiC.
Advanteages has been considered the SiC material which is completely inert substrate combined to
high biocompatibility.
Microfluidics means measuring in microliters, nanoliters or even picoliters. The microfluidics field lies
at the interfaces between biotechnology, medical industry, chemistry and MEMS (micro-electromechanical systems). In these markets, microfluidics is a popular research field, which includes study
of microfluidic possibilities
Development Stage:
Already on the market
Joint further development;Testing of new application
-2-
23.02.11
Halle
Reference: BBS
09 IT 55X5 3DPP
Country: Italy
Medical devices and systems for diagnostics of respiratory diseases, home monitoring and
telemedicine applications
Abstract:
A young and dynamic company based in Rome, with a mission to develop and manufacture devices
and systems which facilitate quality medical testing at reasonable costs,
has designed and developed a complete hardware and software solution for spirometry.
Company s portable spirometry/telespirometry systems with a high degree of technological and
functional innovation are sold worldwide in accordance to safety and quality systems certified by
national and international independent organisations.
Description:
As a leader in the world market of diagnostic spirometry devices and based on an extensive inhouse
know-how, the company develops and produces innovative devices, software plus solutions for
telemedicine applications. These products enjoy an unrivalled reputation for accuracy and product
reliability both amongst lung function specialists and university professors and other opinion leaders
worldwide. The company has designed and developed a complete hardware and software solution
and made the installation and operator training of several telespirometry centres worldwide.
These devices can be easily used by the General Practitioners (family doctors) for screening of the
general population. The patient makes a spirometry test in the doctor s office and then the doctor,
through a simple telephone call without wires or modem, sends the test results to the telemedicine
centre, where a lung specialist is able to make a functional diagnosis. As an other application, these
devices can be used to home-monitor patients affected by chronic respiratory diseases, in order to
improve the quality of life and save hospital costs by the early discharges practice.
Innovative Aspects:
The new health model, based on Tele-health, favours solutions which give a complete and efficient
diagnosis and treatment which increase the quality of the service, reduce costs, improve the flow of
information and produce occupational fall back
Advantages for the patient at home
• personalised management of the disease and continued optimization of the (follow up) treatment.
• improvement in quality of life
• adhesion to a diagnostic / treatment program
• reduction of time for the cycle of symptoms diagnosis treatment
• awareness of the disease and its various levels of severity
•
•
•
•
Advantages for patients in hospital
early dismission made possible by the monitoring of some vital parameters.
reduction in exacerbations thanks to follow up
consequent reduction in the number of hospital admissions due to exacerbations
reduction in the risk of nosocomial infections or of insufficiency for concomitant diseases which
often show up during hospitalisation.
-3-
23.02.11
Halle
Advantages for the health service
• reduction in the number of excess admissions
• swift admission of high risk patients
• improvement in the quality of work and rise in competitivity
• reduction in the costs of process production and distribution for performance
• creation of structured data base of populations for clinical studies, statistics and epidemiology
Advantages for the doctor
• greater degree of safety thanks to monitoring and continued control
• possibility to make timely modifications to the treatment in the case of variations in the clinical
status of the patient, or in critical cases, the possibility to rapidly arrange a visit or admission to
hospital.
Tele-health is able to reach the objective of cutting costs in the healthcare budgets for chronic disease
thanks to:
• reduction in the number of admissions
• reduction in the number of outpatient visits
• reduction in the length time admitted to hospital (early discharges)
Development Stage:
Testing of new applications;Assembly;Engineering
-4-
23.02.11
Halle
Reference: BBS
09 TR 98OF 3FHH
Country: Turkey
Healthcare Information Systems Platform
Abstract:
A Turkish software company developed a healthcare information system which has advanced rule
engines for minimum human intervention. Advantages over conventional healthcare information
systems include its patented enterprise management framework, customized medical data and cost
management applications, its large medical device and drug data bank. The company seeks
healthcare providers interested in further development and testing of new applications.
Description:
The company offers a healthcare information system platform that is developed to fulfill all needs of a
healthcare provider. The offered system has workflow based architecture and it can easily be
integrated with other logistics and ERP systems.The solutions framework contains healthcare
providers' most commonly used operational topics. Healthcare information system framework includes
the following operational modules:
1. Corporate Governance
1.1. Human Resources, Payroll, Rights
1.2. Finance and Accounting
1.3. Supply Chain Management
1.4. Security and Infrastructure
2. Revenue Cycle
2.1. Electronic Data Exchange
2.2. Audit and Fraud Detection
2.3. Health Informatics
2.4. Contract Management
2.5. Rule Engine
3. Core Modularity
3.1. Master Patient Index
3.2. ERP
3.3. Business Intelligence
4. Clinical Processes
4.1. Ambulatory and Emergency
4.2. Policlinic
4.3. Imaging and Diagnostics
4.4. Intensive Care
4.5. Chronic Disease Care
5. Customer Relations Management
5.1. Call Center
5.2. E-Portals
5.3. Medical Assistance
5.4. Personalized Medical Services
6. Medical Data and Cost Management
6.1. Diagnosis Related Groups (DRG) Management
6.2. Clinical Data Collection, ETL and Analysis
7. Data Banks and Medical Identifiers Management
7.1. Medical Devices Data Banks (GS1, GMDN, EAN Compliant)
-5-
23.02.11
Halle
7.2. Drug Data Banks (ATC, ICD Compliant)
8. Payment Systems and Rule Engine Management
8.1. Electronic Payment Systems Applications
8.2. Advanced Rule Engine
Innovative Aspects:
The offered healthcare information system has patented enterprise management framework. The
system is totally flexible and scalable. It can be easily customized to any workflow. One of the other
main advantages of the system its having the world's largest and most sophisticated medical device
and drug data banks. In addition, the system has advanced rule engines for minimum human
intervention.
Development Stage:
Joint Venture Agreement;License Agreement;Testing
-6-
23.02.11
Halle
Reference: BBS
10 BG 0538 3K61
Country: Bulgaria
New technology for development of opto-electronic and laser medical equipement
Abstract:
Bulgarian company has developed equipment for optical biopsy, photodynamic therapy, optical
tomography and optical magnetography. The main advantages are that the equipment could be
applied in domain of dignostics and medical treatment of different diseases, including oncological
diseases. The company is looking for technical cooperation, clinical testing.
Description:
Bulgarian company is specialised in development of equipment for optical biopsy, photodynamic
therapy, optical tomography and optical magnetography. The equipment could be applied in domain of
diagnostics and medical treatment of different diseases, including oncological diseases. The
innovative aspect and the advantages are that this technology and the manufactured equipment for
optical tomography and optical magnetography are new on the international market.
Innovative Aspects:
The innovative aspect and the advantages are that this technology and the manufactured equipment
are new for the Bulgarian market. Some of them, as the equipment for optical tomography and optical
magnetography is new on the international market.
Development Stage:
License Agreement;Financial Resources;Joint further development
-7-
23.02.11
Halle
Reference: BBS
10 DE 0855 3JK2
Country: Germany
Expertise in innovative drug delivery forms for children and the elderly as well as for orphan
diseases treatment and individualised medicine
Abstract:
A German university institute offers its special expertise in innovative drug dosage forms, delivery
devices, new excipients with improved properties and novel formulations for an effective and safe drug
therapy in paediatrics, geriatrics, personalized medicine and orphan diseases. Innovative companies
from the pharmaceutical industry are sought for technical cooperation and joint development of new
products.
Description:
The application of a drug molecule to the human body is a key challenge in drug therapy. Special
groups of patients such as children or elderly have different demands than normal adults . Paediatric
formulations are a basic requirement for an effective and safe drug therapy in children and
adolescents. Therefore, early taste assessment by electronic tongues and taste masking of
pharmaceuticals are major topics.
A German university institute is developing novel products with innovative drug dosage forms, delivery
devices, new excipients with improved properties and novel formulations. Beside liquid formulations
with improved taste properties, various solid drug dosage forms with small dimensions such as pellets
or minitablets have been developed and in some cases already introduced to the market by the
industrial partners of the institute. Moreover, new delivery devices such as minitablet counter and
tablet pens, for delivering individual doses of the active ingredient in a safe and easy manner are
under development.
Innovative Aspects:
- Expertise in accordance with the growing market potential of personalised medicine, drug delivery for
the elderly
- Reduction of adverse effects of current drug delivery methods, especially in children and the elderly
- Know-how covers different aspects of drug delivery such as dosage, delivery devices, excipients and
formulations
Development Stage:
Development phase - Laboratory tested
Joint further development;Testing of new applications
-8-
23.02.11
Halle
Reference: BBS
10 ES 24E1 3IPO
Country: Spain
An Ambient Intelligence Based Multi-Agent System for Alzheimer Health Care
Abstract:
A Spanish university has developed a technology for the development of an ambient intelligence
based multi-agent for Alzheimer health care.
One of the most important characteristics is the use of intelligent agents as the main components in
employing a service oriented approach, focusing on distributing the majority of the systems
functionalities into remote and local services and applications.
The University is interested in license, technical cooperation and commercial agreements.
Description:
The importance of developing new and more reliable ways of providing care and support for the
elderly is under-scored by this trend, and the creation of secure, unobtrusive and adaptable
environments for monitoring and optimizing health care will become vital. Some authors consider that
tomorrow s health care institutions will be equipped with intelligent systems capable of interacting with
humans. Multi-agent systems and architectures based on intelligent devices have recently been
explored as supervision systems for medical care for dependent people. These intelligent systems aim
to support patients in all aspects of daily life, predicting potential hazardous situations and delivering
physical and cognitive support.
Ambient Intelligence based systems aim to improve quality of life, offering more efficient and easy
ways to use services and communication tools to interact with other people, systems and
environments. Among the general population, those most likely to benefit from the development of
these systems are the elderly and dependent persons, whose daily lives, with particular regard to
health care, will be most enhanced.
Agents and multi-agent systems in dependency environments are becoming a reality, especially in
health care. Most agent-based applications are related to the use of this technology in the monitoring
of patients, treatment supervision and data mining.
It is a distributed multi-agent system designed upon Ambient Intelligence and aimed at enhancing the
assistance and health care for Alzheimer patients living in geriatric residences. The main
functionalities in the system include reasoning and planning mechanisms that are embedded into
deliberative BDI (Believe Desire Intention) agents, and the use of several context-aware technologies
to acquire information from users and their environment. The main characteristics of the system are
described, followed by a description of the new system developed by means of the FUSION@
architecture. FUSION@ is a modular multi-agent architecture, where services and applications are
managed and controlled by deliberative BDI agents.
Its structure has five different deliberative agents based on the BDI model (BDI Agents), each one with
specific roles and capabilities:
User Agent. This agent manages the users personal data and behaviour (monitoring, location, daily
tasks, and anomalies). The User Agent beliefs and goals applied to every user depend on the plan or
plans defined by the super-users. User Agent maintains continuous communication with the rest of the
system agents, especially with the ScheduleUser Agent (through which the scheduled users can
communicate the result of their assigned tasks) and with the SuperUser Agent. The User Agent must
ensure that all the actions indicated by the SuperUser are carried out, and sends a copy of its memory
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
E-Mail: [email protected]
URL: www.tti-md.de
-9-
23.02.11
Halle
base (goals and plans) to the Admin Agent in order to maintain backups. There is one agent for each
patient registered in the system.
SuperUser Agent. This agent runs on mobile devices (PDA) and inserts new tasks into the Admin
Agent to be processed by a reasoning mechanism. It needs to interact with the User Agents to impose
new tasks and receive periodic reports, and with the ScheduleUser Agents to ascertain the evolution
of each plan. There is one SuperUser Agent for each doctor connected to the system.
ScheduleUser Agent. It is a BDI agent with a planning mechanism embedded in its structure. It
schedules the users daily activities and obtains dynamic plans depending on the tasks needed for
each user. It manages scheduled-users profiles (preferences, habits, holidays, etc.), tasks, available
time and resources. Every agent generates personalized plans depending on the scheduled-user
profile. There is one ScheduleUser Agent for each nurse connected to the system.
Admin Agent. It runs on a Workstation and plays two roles: the security role that monitors the users
location and physical building status (temperature, lights, alarms, etc.) through continuous
communication with the Devices Agent; and the manager role that handles the databases and the task
assignment. It must provide security for the users and ensure the efficiency of the tasks assignments.
There is just one Admin Agent running in the system.
Innovative Aspects:
This multi-agent system aimed at enhancing the assistance and health care for Alzheimer patients. It
takes advantage of the cooperation among autonomous agents and the use of context-aware
technologies providing a ubiquitous, non-invasive, high-level interaction among users, system and
environment.
Development Stage:
Testing of new applications
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 10 -
23.02.11
Halle
Reference: BBS
10 ES 27F3 3GL9
Country: Spain
Design technique of microsurgery for the implantation of tissue or the release of biological
substances in the brain tissue
Abstract:
An Andalusian research group (Spain) has developed some techniques of microsurgery for the
implantation of tissue or biological release of substances in the brain tissue . It is aimed at companies
manufacturing devices for the release of substances in the brain or institutions working in the field of
neurological microsurgery. The institute seeks to transfer the patent rights through entering into
license agreements.
Description:
The research group has developed techniques for stimulation and recording by telemetry in vivo and
the mechanisms of potentiation and long-term depression (LTP and LTD) in vivo in various species.
These experimental models are likely to be used for mapping and pharmacological study of learning
ability and memories of wild, transgenic and mutant mice.
Various techniques are also available for micro-injection, micro-dialysis and micro-stimulation, as well
as recording techniques in vivo (unit and field records) of the brain electrical activity
The group has developed a program of analysis and representation of biopotentials by wavelet
techniques as well as micro-surgical techniques for implantation of tissue, cell suspensions, micropumps and other substances that should be released with great accuracy within the brain tissue.
Innovative Aspects:
• Classical and instrumental conditioning in mammals.
•
Facilitates tissue implantation, micro-pumps and other devices within the brain tissue.
•
High domain techniques specializing in the study and introduction of substances in the brain
tissue.
Development Stage:
Available for demonstration
Joint Venture Agreement;License Agreement;Joint further development
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 11 -
23.02.11
Halle
Reference: BBS
10 ES 28F9 3H4Q
Country: Spain
Simulator technology for clinical medical cases
Abstract:
A company based in Spain specialized on IT and ICT Engineering, has developed a software
technology for simulating medical cases. The technology is an innovative tool design for education
and training of healthcare professionals, particularly doctors to practice real medical cases following
similar working process to those carried out in real life. The conpany is looking for healthcare
professional organisations, public or private, interested in licensing or distributing the technology.
Description:
The medical clinical simulator system is a tool based on real clinical cases that interacts with users.
The tool is aimed at the resolution of queries of patients who enter a virtual hospital. The application is
presented with attractive and functional design and has a user-friendly navigation structure. The
objective is to make a correct diagnosis and to take effective action following the correct protocol.
This technolgy has been designed for healthcare professionals, especially medical specialists, primary
care professionals and medical students. The cases are varied reflecting the diversity of pathologies
and can be adjusted to the client´s needs.
The immediate future in training and medical practice through simulation of actual cases of clinical
settings on virtual patients.
• Virtual environment, which is modeled on real-life medical practice:
• Protocols and operational procedures
• Habits of the physician
• Full equipment of a hospital
• Virtual and complete patient information
• Real-life clinical cases are documented
• Performed by medical staff
• Report of analysis of all the steps performed by the physician:
• What was successful and why
• What has been done incorrectly and why
• What was missing and which should have been the most appropriate action
• Complete catalogue of most prevalent cases which is very important not only for diagnosis
but also enables tracking the performance protocol
• Different levels of difficulty according to the target audience
• Possibility to follow-up studies on medical protocols and habits
• Possibility to create a specific case that a group of professionals might require.
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 12 -
23.02.11
Halle
Technical Features: Presentation (Multiplatform):
• Simulator: Adobe Director Shockwave, Adobe Flash
• Administration: HTML, PHP
• Case creation: HTML, PHP, AJAX
• Data Access: MySQL
• Multilanguage at presentation and data level: English, Spanish and German.
Innovative Aspects:
Medical Clinical Simulator is a tool of proven interest in medical settings:
• Interest by medical institutions.
• Market research values with 9 out of 10 points the usefulness of the simulators and the
interest for the medical profession.
• Reports at European level recommending simulation in medical training.
Benefits for the Healthcare sector:
• Healthcare professional can practice on virtual patients
• Valuable data to increase the quality of the medical practise.
• Evaluate medical practice behaviour and performance
• Educational platform with a full range of cases that can be tailored to specific needs.
• Tool for practice and training in order to reduce diagnosis errors.
• Your organization can improve processes, increase quality and reduce costs.
Development Stage:
License Agreement;Assembly;Engineering;Technical cooperation
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 13 -
23.02.11
Halle
Reference: BBS
10 GB 41n8 3ILK
Country: United Kingdom
Bioanalysis expertise in human health research studies and drug development
Abstract:
A UK analytical company provides expertise & analysis for clients related to human health research,
diagnosis and monitoring. With over 20 years experience they are one of the leading analytical
companies in support of health surveys, smoking cessation programmes, epidemiological studies,
novel drug development and the reformulation of existing drugs. The MHRA GLP/GCP accredited
company offers its expertise and facilities and is looking for technical cooperation with research
centres etc.
Description:
Today the majority of healthcare research requires the support of analytical assays. For many the
purchase of the sophisticated analytical equipment and the employment of the skilled staff and the
associated running costs is not a cost effective way to support individual research projects. The
added-value of experience and expertise required in the challenging analysis process (e.g. method
development, method transfer, sample analysis) is rather more difficult to access.
The UK analytical company has specialised in bioanalysis (quantifying analytes in biological fluids)
over the past thirty years. They believe this focus enables them to deliver an excellent customer
centred service at a competitive price. Their work has resulted in the publication of over 500 scientific
papers in peer reviewed journals as well as reports in numerous scientific TV programs, books etc. As
you would expect their staff are extremely skilled and innovative in developing, validating and
supporting quantitative measurements in biological matrices. They routinely apply existing analytical
methods or develop bespoke bioanalytical methods in partnership with their sponsors to satisfy
business needs.
Innovative Aspects:
The UK company has a wealth of experience, expertise and equipment in delivering cost-effective
results for clients in the crucial area of bioanalysis. For example they have many years experience of
assaying nicotine and cotinine in saliva, plasma and urine, and supported various studies investigating
smoking status and tobacco smoke exposure in adults and children. Their assay is sensitive enough
to give a measure of passive smoke exposure.
They have also established a strong reputation in the field of analytical support for the measurement
of drugs of abuse and provided all the pharmacokinetic data to support the development of cannabis
based medicines within the UK.
As you would expect from such a professional GLP/GCP accredited laboratory they supply sample
collection kits, have a variety of validated assays, store samples under closely monitored temperature
controlled environments and deliver automated reports as required.
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 14 -
23.02.11
Halle
Development Stage:
Testing of new applications;Quality control
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 15 -
23.02.11
Halle
Reference: BBS
10 GB 46P4 3IHL
Real time patient flow and bed management system used in hospital environments
Abstract:
A Scottish SME has developed a real time, multi-functional patient flow and bed management system
to enable clinical and management staff to efficiently manage patient care and view a real time bed
state. The system is in use at 15 sites in the UK.
The company is interested in license and technical co-operation and commercial agreements with
healthcare organisations looking to improve performance and patient care as well as relevant IT
partners/system integrator.
Description:
A Scottish SME has developed a real time, multi-functional patient flow and bed management system
to enable clinical and management staff to efficiently manage patient care and view a real time bed
state. The system is in use at 15 sites in the UK.
By replicating existing clinical information tools (for example whiteboards, handover forms)
electronically, the system gives users real time, easily understood information, presented via an
intuitive graphical interface, with drag and drop functionality.
Developed with the input of clinical and mangement staff, this system allows staff to monitor
admissions, discharges, bed availability, bed blocking and patient needs across all wards and so
allocate patients to the best locations to maximise quality care. Key features include:
• Real Time Bed State
• Ward Whiteboard Display
• Electronic Patient Record
• Bed Managers Tools and Reports
• Bed Requesting and Tracking
• Automatic Consultant Team Patient Lists
• Team Case Loads
• Activity Alerts and Action Tracking
• Ward Handover Notes & Doctor's (Teams)Handover Notes
• Observations and Assessments
• Doctor's Take List Management
The system benefits various users including Ward Nurses, Ward Managers, Matrons, Consutants,
Doctors of all grades, Bed Managers, Site Coordinators, Discharge Managers, Social Workers,
Radiology staff, Pharamacists and other specialists. In addition the solution provides controlled and
restricted access to Porters, Receptionsts and other Admin staff who may need to locate a patient but
can see no other details.
The system is easy to use requiring minimum training (approximately 40 - 45 mins) which has resulted
in maximum engagement by existing customers.
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 16 -
23.02.11
Halle
•
•
The system has a number of add-ons including:
GP Direct - listing pre-admit General Practicioner (GP) referrals.
•
Mobile Medic - electronic bleep and information system allowing doctors and site-coordinators
to communicate while on the move.
•
Infection Tracking - automatically recording all patient movements and time, identify isolation
beds, tracking bed cleans, monitoring infection levels etc.
•
Electronic Discharge Letters - helping doctors produce complete, accurate and legible
discharge summaries quickly and easily.
•
Pharmacy Patient Tracking - allowing Pharmacy Teams to track the medicines reconciliation
process for every patient admitted.
•
The system is offered as a standalone product or as part of a suite of software solutions aimed
at various aspects of healthcare management.
Innovative Aspects:
The Scottish company has been recognised by the UK investment and enterprise community
for its innovative solutions.
•
•
This patient flow solution replaces an approach that in many places is still paper based and thus
ineffective and error prone.
Used in multiple locations in the UK, the system has shown the following benefits:
•
•
•
•
•
•
•
•
Instant, real time, visual, accurate picture of the status of the patients and the bed state;
Clinician friendly format increases clinical engagement;
Wide range of executive management, performance reports created from data collected;
Facility to accurately predict bed status in any time frame through accurate predicted
Discharge Dates;
Discharge process improved;
Highlights problem discharges in advance;
Improve communication and reporting, assist handovers;
Dramatic reduction in time spent filling in paper by hospital staff.
Development Stage:
License Agreement;Adaptation to specific needs;Technical cooperation
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 17 -
23.02.11
Halle
Reference: BBS
10 GB 46P4 3IZG
A novel solution for surface cleaning products (such as wipes and sprays) in healthcare
environments
Abstract:
A Scottish company has developed a range of biocidal products with ingredients that are not toxic and
are perfectly safe for the environment. The product has completed successful trials with a major
healthcare player in the UK and has been shown to be effective as a surface cleaner, hand wash and
wipe. Companies in the healthcare sector, which are interested in technical cooperation to look at
sustainable effective cleaning methods are sought to commercialise these products.
Description:
A Scottish company has developed a range of biocidal products based on Hypochlorous acid, the
chemical produced by the human body to kill microorganisms. Available as a surface cleaner, hand
wash (liquid or foam) or wipe. The range does not have the toxicity and consequent health and safety
issues of established chemical agents and therefore offers a safer more effective approach to good
hygiene standards.
Innovative Aspects:
Independent evaluation of the product has demonstrated that the product is very fast acting, resolving
the contact time required of conventional biocidal agents.
In addition to its low toxicity and environmental impact the product is safe for use by staff, presenting
added value over other active agents.
Development Stage:
Adaptation to specific needs;Technical consultancy
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 18 -
23.02.11
Halle
Reference: BBS
10 NL 60AH 3JZE
Country: Netherlands
The development and production of medical and healthcare instruments based on the
processing of physiological signals
Abstract:
A Dutch SME is specialized in the development and production of special medical instruments that are
processing physiological signals. Customized to the need of the partner the SME offers development
expertise, co-engineering, production and testing activities and service for those medical instruments.
The main advantage is the complementarity to the needs of a technostarter. The Dutch SME is
interested in commercial agreements supported by development, production and technical assistance.
Description:
A Dutch SME is specialized in the development and production of high quality products for the health
and life science market and industrial market based on long-term business agreements. Especially for
the health and life science the company has much experience and a long history with the codevelopment, redesign and production of medical instruments based on the signal processing of:
• Optical signals;
• Electro physiological signals;
• Pressure signals.
Further other important to mention characteristics of the SME are related to quality, lean
manufacturing, supply chain optimization and the support to realize a business concept. Each
characteristic is elaborated below:
Quality:
The company is ISO 13485 certified and the system is open to cooperation processes with partners or
clients. This gives the advantage to partners to realize a medical valorization programme with minimal
costs without obtaining directly beforehand needed ISO certification for the partner. Also the
production department is IPC-A-610D class 2 certified.
Lean manufacturing:
The production facilities of the company can handle both small series and big series. The production
employees are used to work in flexible workstations with the concepts of lean manufacturing and rapid
tool setting.
Supply chain optimization:
To realize a complete product the company works with a network of partners with complementary
expertise and production capacities. During the process of upscaling the production from prototyping,
pilot production, small series production to bigger series production the supply chain optimization is
continuously in the focus of the attention of the company. The ultimate goal is to design and produce
high quality products in the most economical way.
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 19 -
23.02.11
Halle
Support to realize the business concept:
The company has a strong desire to establish sustainable (long term) win-win relations with partners.
They understand that support is needed to realize business concepts. Important advantages of the
company are the full commitment and the complementarity to the needs of a technostarter.
Concerning the profile of the technostarter it is desired that they have firstly a functional prototype and
secondly access to a launching customer or the first market.
Innovative Aspects:
The innovative features of the medical instruments produced by the SME are based on the latest state
of the art of the technology of the signal processing of:
• Optical signals;
• Electro physiological signals;
• Pressure signals.
The advantages of the offer are:
• Complementarity to the needs of a technostarter that possesses a functional prototype and a
first access to the market;
• Production capacity without the need for a partner to have ISO certification;
• Lean manufacturing;
• Supply chain optimization that will adapt to the current phase of the product life cycle;
• Support to realize the business concept.
Development Stage:
Joint further development;Testing of new applicatitions
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 20 -
23.02.11
Halle
Reference: BBS
11 BE 0213 3KAQ
Country: Belgium
Organs isolated perfusion technology
Abstract:
A Brussels-based company is pioneering the use of percutaneous organ isolation and perfusion
procedures in the emerging market of interventional oncology. The catheter based system enables a
temporary and complete separation of the liver from the systemic blood system and permits
administration of chemotherapy drugs at high concentrations directly into the isolated liver, under drug
optimized conditions without systemic side effects. Commercial agreement with technical assistance is
sought.
Description:
Administering drugs directly into an isolated closed organ permits local delivery of the optimal
pharmacological dose without exposing other organs to drug toxicity and provoking systemic side
effects. The lead product of the Brussels-based company is a Liver system. It is a set of catheterbased devices intended to be used in combination with physician selected chemotherapy drugs for the
treatment of cancer metastases in the liver. Currently, surgical resection is the only potentially curative
treatment available for patients with cancer metastases in the liver. However, it is only suitable for a
small number of patients due to the quantity, size or location of the metastases. Systemic, palliative
chemotherapy treatment is typically given to these patients. Because the drug is administered
systemically, it has a relatively low concentration in the liver, rendering it less effective. It is for these
patients that Liver system will offer a potentially new curative treatment option. The potential market
size for this product has been estimated by independent, outside consultants to be about 3 billion EUR
in US + Europe alone. The company is initially pursuing an open drug strategy i.e. the system can be
used with physician prescribed drugs. Later, device / drug combination products will be added through
partnerships with pharma companies. The company has established a Medical Advisory Committee
consisting of, amongst others, leading experts and opinion leaders in Gastro-Intestinal Oncology and
Interventional Radiology which help to direct the development of the system close to user' needs and
ahead of competitive developments. The system has received worldwide patent protection. The
system is developed and manufactured according to ISO norms certified facility in Brussels. The
system has successfully passed laboratory tests and in vivo animal trials. A first clinical trial bas been
started in 2010 and will lead to the obtention of the CE-mark during spring 2011.
Innovative Aspects:
This will be the first system available to isolate and perfuse a human organ with minimal invasive
procedures. There is no curative medical alternative available today.
The main advantages are the following:
-No side effects of the drugs: the system enables a circulation of the drugs in a closed circuit,
impacting directly the metastases and impeding the circulation of the chemical in the whole body
An increased clinicial efficency of the chemical product
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 21 -
23.02.11
Halle
Development Stage:
Financial Resources;Absolutely novel process;Technical cooperation
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 22 -
23.02.11
Halle
Reference: BBS
11 DE 1375 3K6G
Country: Germany
General diagnostic device to control organs and therapies
Abstract:
A medical doctor from Germany developed a diagnostic device to control the functions of vital organs.
His small company is producing this general diagnostic
device. For further developments he is seeking for international partners.
Companies interested in a licence to develop the next product generation
based upon this method are sought.
Description:
A medical doctor from Germany developed a diagnostic device to control the functions of vital organs.
The device based on modulation of different frequencies and the measurement
of the specific electrical conductivity has been applied to the patients of
the doctor's medical practice.
The conventional diagnoses done by specialists thereafter have been accurately documentated. In the
next step the results of the measurements were matched with the ones of the conventional diagnose.
This long time study lead to the general diagnostic device.
It provides instant prediction about the current vegetative situation of the person being evaluated.
Further a therapy can be supported by a continous control with the device: The right amount of
medicinal dose as well as the time to drop from the therapy can be determined by the measurements
and thus reduce the medical side effects.
Innovative Aspects:
• Harmless check of the functions of vital organs.
• Proofed approach to control medication and therapies.
Development Stage:
Joint Venture Agreement;License Agreement;Joint future development
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 23 -
23.02.11
Halle
Reference: BBS
10 IL 80EP 3HV3
Country: Israel
PHR (Personal Health Records) software applications that can be integrated with a USB Flash
memory drive
Abstract:
An Israeli SME that has developed a patented secure USB Flash memory Drive that is affixed on a
wallet compatible card (size of a credit card) seeks PHR (Personal Health Records) software
applications for integration with its USB card for providing a full PHR solution. The solution will be
offered to healthcare service providers and other organizations that provide full PHR solutions. An
Israeli SME that has developed a patented secure USB Flash memory Drive that is affixed on a wallet
compatible card (size of a credit card) seeks PHR (Personal Health Records) software applications for
integration with its USB card for providing a full PHR solution. The solution will be offered to
healthcare service providers and other organizations that provide full PHR solutions. An Israeli SME
that has developed a patented secure USB Flash memory Drive that is affixed on a wallet compatible
card (size of a credit card) seeks PHR (Personal Health Records) software applications for integration
with its USB card for providing a full PHR solution. The solution will be offered to healthcare service
providers and other organizations that provide full PHR solutions. Partners are sought for technical,
commercial cooperation and joint ventures.
Description:
The company is presently providing its secure USB cards for many applications (including commercial
PHR applications) in Europe and the USA. The card includes an SDK (Software Development Kit) for
easy integration with the PHR software applications.
•
•
•
•
•
The company and the partner will cooperate in order to develop comprehensive solutions for
the PHR market.
A comprehensive PHR solution will include the USB card, the integrated PHR software, the
servers and the support services will be offered to healthcare service providers and other
organizations that seek to provide full PHR solutions,
The solutions should be addressed to large hospitals, health care provider and/or nation wide
medical projects..
Joint Venture Agreement, License Agreement, Joint further development, Testing of new applications
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 24 -
23.02.11
Halle
Reference: BBS
10 IL 80EP 3JIY
Country: Israel
Technologies, applications and capabilities for telemedicine, telehealth and telecare
Abstract:
An Israeli SME, a global developer and provider Telemedicine, Telehealth and Telecare products and
solutions, seeks partners having complementary technologies,applications and/or capabilities for joint
ventures in order to enhance their product offerings and market position.
Description:
The Israeli SME is an award winning provider in cost-effective, high quality, user-friendly, medical
diagnostic systems and devices for home care, eHealth and telemedicine as well as telecare and
personal safety.
The company provides a complete disease management package; including transtelephonic devices
designed for a variety of remote diagnostic, emergency services and monitoring applications,
hardware and software platforms for remote monitoring call centers, as well as phone and web-based
monitoring software. the company enables patients to conduct tests comfortably while leading normal,
mobile lives.
The company, providing solutions in over 45 countries, seeks to enhance their line of products and
services through the adoption of technologies, applications or capabilities suitable to incorporate into
their offerings that transmit health and lifestyle related data via a variety of media (such as phone
lines, cellphones, the Internet or wireless) for online monitoring, analysis and care, when and where it
is needed.
J Joint Venture Agreement, Joint further development, Testing of new applications, Adaptation to
specific needs
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 25 -
23.02.11
Halle
Reference: BBS
10 ES 25E2 3J2K
Country: Spain
Seeking new technologies to foster Health Services
Abstract:
A Catalan SME with vast experience in eHealth and Telemedicine projects is looking for new
technologies to create new services and improve current ones. The company is specialist in
integrating solutions to provide full service in new tele-health or health services.
They are looking for new competitive technologic solutions to enable new or improved biometric data
capture, wireless & ubiquitous communciations, data integration into Information Systems and
Business Intelligence solutions.
Description:
The objective is both to improve current services with innovative attributes, and to extend the service
range currently offered to our clients: Care Delivery Organisations, insurance companies and
pharmaceutical companies. In a broad sense, the company looks for new monitor systems for home
care (example: cardiotocography for home monitoring), new services (viodeoconferencing with quality
and safe communications), business intelligent solutions proven in clients from the sectors mentioned
previously.
They are looking for new hardware, software or services to overpower current offered solutions and to
create new products for their clients. Some examples of the sought technologies are:
•
•
Hardware: New biometric devices (example of current need: low cost cardiotocography
monitor for home use), Gateway devices, health stations
Software: any innovative development for telemedicine dealing with a concrete pathology,
multi-pathology, services (video conferencing, e-visit,...), home or hospital, mobile monitoring,
predictive applications, preventive contents.
Joint Venture Agreement, License Agreement, Joint further development, Testing of new applications
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 26 -
23.02.11
Halle
Reference: BBS
10 FR 38m5 3IW2
Country: France
PS: FP7-KBBE-2011-5-SME : SME sought for project under topic Processed foods with
lower salt, fat and sugar content
Abstract:
A french coordinator seeks SMEs for a FP7 project aiming at reducing the level of salt, sugar and fat
in selected cheese, meat, bread and ready-made food products (sauces) whilst maintaining nutritional
and sensorial qualities of these products to ensure full consumer acceptance. SMEs from the food
industry are sought for testing, application and demonstration activities.
Description:
Most developed country are confronted with a rising rate of pathologies such as obesity,
cardiovascular diseases, diabetes which are related to non well-balanced diets and excess of
consumption of fat, salt and low-size sugars. A significant reduction of these ingredients in food should
contribute both to save numerous lives and reduce healthcare costs. However, their multifunctionality
gives difficult qualitative and quantitative changes in their composition.
The aim of the project is to reduce the level of salt, sugar and fat in selected cheese, meat, bread and
ready-made food products (sauces) whilst maintaining nutritional and sensorial qualities of these
products to ensure full consumer acceptance. This will be done by fine-tuning current product
formulations by engineering the technological parameters of realistic food models specific to each
product. In parallel, micro- and microstructures of the new food matrices will be studied. To ensure the
sensorial feasibility of this re-engineering, sensorial analysis and optimisation to ensure consumer
acceptability will be carried out in parallel to these technological developments. Moreover, the
nutritional value of reformulated foods will be estimated compared to the non reformulated ones.
Beside technological aspects, more fundamental studies from selected models developed above will
be conducted to improve the understanding of the main mechanisms leading to perception. That
includes flavour release and temporal perception in relation with changes in composition of the
selected models with in vivo and in vitro approaches with predictive tools, and a cognitive approach
will be carried out as a promising lever to compensate salt, sugar and/or fat reduction. The findings will
be transferred to the reformulation actions to study the possibility to be introduced in the food process.
These new product formulations will be validated via extensive demonstration activities with several
SMEs for different European countries including a cost-benefit analysis in terms of industrial feasibility
and consumer acceptance on large populations.
Joint further development, Testing of new applications
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 27 -
23.02.11
Halle
Project Proposal
Improvement and Development of new multicentre clinical trials to detect and reduce
diabetes complications
Type Details: Main goals:
1. Identification of Diabetes Complications Risk Factors.
2. Identification of Diabetes Complications Origin and Evolution Mechanisms.
3. Development of new diabetes detection and prevention methodologies and technologies.
4. Development of techniques and technologies for the treatment of diabetes complications.
5. Development of a Public Diabetes Database.
Most of tasks will be deployed for each and every complication to be studied (neurodegenerative,
micro-vascular, immunological and/or hepatic origin).
Suggested TASKS:
- Coordination
- Prospective study on diabetes complications and their treatments
- Design and development of early diabetic complication detection tools
- Design and development of tools for preventing diabetic complications
- Clinical trials design for the detection of early diabetic complications
- Clinical trials design for the prevention and treatment of diabetic complications
- Database analysis, design and implementation
- Multicentre Clinical Trials
- Data storage
- Analysis and Validation of results
- Exploitation and dissemination
Our idea is to prepare a proposal for the topic HEALTH.2011.2.4.3-1: Investigatordriven clinical trials
to reduce diabetes complications (call FP7-HEALTH-2011-two-stage).
Programme (Collaboration EU R&D): FP7-HEALTH
Expiry Date: 2011-09-15
Target Partner
1. EXPERTISE REQUESTED: MULTICENTRE CLINICAL TRIALS; DATA GATHERING
ROLE: Partner
ORGANISATION TYPE: MEDICAL CENTER OR CLINIC
2. EXPERTISE REQUESTED: Clinical Trial Design; Diabetes Tools Development
ROLE: Coordinator
ORGANISATION TYPE: Research Centre
3. EXPERTISE REQUESTED: Medical Tool Development; Pharmaceutical research
ROLE: Partner
ORGANISATION TYPE: SME
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 28 -
23.02.11
Halle
Project Proposal
NETWORK PREVENTATIVE AND THERAPEUTIC HEALTH
Type Details:
Define the scientific criteria concerning the medical-biological disciplines of thalassotherapy, spa
activities and their adjuvant therapy applied in preventive medicine, clinic and therapy, and structural
and environmental requirements hygienistic buildings, adequate systems of health care management
and cost effectiveness. This entire plus is also according to the law that these disciplines are the
exclusive domain of medicine and surgery.
The ultimate objective of the study is define specific scientific criteria and mechanisms of action at the
soma in the globality' and districts organ.
It aims to intervene in a European network with exchanges of know-how in the treatment of primary
secondary tertiary prevention, preventable and treatable disease with the disciplines identified. In the
evaluation of follow-up of patients, prospective longitudinal studies will be applied case - control.
Target Partner
Expertise: Any company, university, research center and organization working on:
in the disciplines of thalasso therapy, spa activities and their adjuvant therapy applied in preventive
medicine, clinical and therapeutic
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 29 -
23.02.11
Halle
Project Proposal
Health care for women affected by violence in Austria
Type Details:
The Word Health Organization names violence against women as one of the top health risks for
women and girls. Although some activities have been launched the healthcare system in Austria still
does not adequately and consistently address affected women.
Some provinces like Styria, Lower Austria, Vienna and Tyrol started with training programs for health
professionals in hospitals or in educational institutions. In March 2010 the first national guideline
'Health care for women affected by violence - A guideline for hospitals and medical practice' was
launched by the Ministry of Economics, Family and Youth. The Women's Health Center is an active
member of a national group of women's activists from different sectors and professional backgrounds
lobbying for the implementation of this national guideline in all provinces.
Project: Health effects of violence against women
In 1997 experts in women's shelters developed the first Austrian curriculum 'Violence against Women'
to train health professionals in Lower Austria. Due to excellent evaluation results of these trainings, the
Women's Health Center in Graz transfered this model to Styria conducting a 15 month project in
cooperation with the Styrian Hospital Corporation of the public hospitals KAGes (from October 2007 to
December 2008). The training builds awareness on different forms of violence against women, short
and long term health effects and the importance of the health care system as the place to go for
affected women. Furthermore the participants learned about adequate intervention, documentation,
the legal background and outpatient women's shelters and service centers.
We offer
- Knowledge of and contact with the key players in the field of violence against women and the health
care system
- Expertise in lobbying, networking and public relations
Target Partner
Expertise: We are looking for partners to
- exchange knowledge and experiences
- develop a national action plan to fight the health effects of violence against women
- implement violence against women as a required subject in education and training of health staff
- develop specialized trainings for midwives, psychiatric clinics, home care
- carry out scientific evaluation and research
- coordinate the project
Contact:
Helga Ilchmann
Tel.: 0391 – 7443542
Fax: 0391 – 7443544
URL: www.tti-md.de
- 30 -

Europäische Förderprogramme zu Medizin

Transcription

Documents pareils

Glass pipes for sale - Hookah Online Store

- Aero-naut

Der witz und seine beziehung zum unbewussten pdf

DI20121115 promocard sockstar.indd

Big Data Analyst (m/f) (Data- Warehouse-Analyst/in

seminar invitation - Lehrstuhl für Systemdynamik und Prozessführung

LC-310 - MS-Tech

Press release - MEDIA CONSULTA: Home

Allowable Number of Cycles due to German AD

STEP IMS - STEP Sensortechnik und Elektronik Pockau GmbH

MYSO Audition Excerpts - Bass D. Ludwig van Beethoven, Ode to